Point-of-care monitoring of infliximab trough levels in capillary fingerstick blood of patients with inflammatory bowel disease (IBD)

被引：0
|
作者：
Maljaars, J. [1 ]
de Dood, C. [2 ]
van der Burg, S. [1 ]
van der Meulen, A. [1 ]
Tanke, H. [2 ]
Corstjens, P. [2 ]
机构：
[1] LUMC, Gastroenterol Hepatol, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Mol Cell Biol Geb 1, Leiden, Netherlands
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP039
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [1] DETERMINATION OF SERUM INFLIXIMAB LEVELS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE, COMPARISON OF POINT-OF-CARE AND ELISA IMMUNOASSAY
    Burti, C.
    Ciafardini, C.
    Mazza, S.
    Scaramella, L.
    Vecchi, M.
    Caprioli, F. A.
    [J]. DIGESTIVE AND LIVER DISEASE, 2020, 52 : S126 - S126
  • [2] COMPARATIVE ASSESSMENT OF INFLIXIMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Maniero, D.
    Lorenzon, G.
    Marsilio, I
    Rigo, A.
    Cardin, R.
    Facchin, S.
    Barberio, B.
    D'Inca, R.
    Zingone, F.
    Bahur, B.
    Bray, K.
    Savarino, E., V
    [J]. DIGESTIVE AND LIVER DISEASE, 2021, 53 : S162 - S162
  • [3] Comparative Assessment of Infliximab Trough Levels between Point-of-Care Testing and current Standard of Care (enzyme linked immunosorbent assay) in patients with Inflammatory Bowel Disease
    Maniero, D.
    Lorenzon, G.
    Marsilio, I.
    Rigo, A.
    Cardin, R.
    Facchin, S.
    Barberio, B.
    D'Inca, R.
    Zingone, F.
    Bahur, B.
    Bray, K. R.
    Savarino, E. V.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S325 - S325
  • [4] RAPID POINT-OF-CARE MONITORING OF ANTI-INFLIXIMAB ANTIBODIES AND CLINICAL SCORES IN INFLAMMATORY BOWEL DISEASE PATIENTS
    Facchin, S.
    Buda, A.
    Cardin, R.
    Agbariah, N.
    Zingone, F.
    De Boni, M.
    D'Inca, R.
    Savarino, E.
    [J]. DIGESTIVE AND LIVER DISEASE, 2019, 51 : E110 - E111
  • [5] Performance of a New Rapid Point-of-Care Test for Infliximab Levels in Patients with Inflammatory Bowel Disease: A Comparison to ELISA
    Valdes-Delgado, Teresa
    Aguado-Paredes, Alicia
    Merino-Bohorquez, Vicente
    Martin-Manzanares, Jesus
    Alonso, Maria Mercedes
    Maldonado, Belen
    Castro, Luisa
    Belvis, Maria
    Benitez, Beatriz
    Caunedo, Angel
    Calleja, Miguel angel
    Arguelles-Arias, Federico
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (01) : 228 - 234
  • [6] Performance of a New Rapid Point-of-Care Test for Infliximab Levels in Patients with Inflammatory Bowel Disease: A Comparison to ELISA
    Teresa Valdés-Delgado
    Alicia Aguado-Paredes
    Vicente Merino-Bohórquez
    Jesús Martín-Manzanares
    María Mercedes Alonso
    Belén Maldonado
    Luisa Castro
    María Belvis
    Beatriz Benítez
    Ángel Caunedo
    Miguel Ángel Calleja
    Federico Argüelles-Arias
    [J]. Digestive Diseases and Sciences, 2024, 69 : 228 - 234
  • [7] Infliximab Dosing for Patients With Inflammatory Bowel Disease, Based on Trough Levels
    Lowe, Anson W.
    Moseley, Richard H.
    [J]. GASTROENTEROLOGY, 2015, 148 (07) : 1261 - 1261
  • [8] Point-of-care infliximab quantification in inflammatory bowel disease in daily practice
    Costa Santos, M. P.
    Palmela, C.
    Gouveia, C.
    Fidalgo, C.
    Gloria, L.
    Cravo, M.
    Torres, J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S484 - S484
  • [9] Novel capillary blood point-of-care test for adalimumab and infliximab trough levels: Effects of abnormal blood conditions on the test result
    Brosi, L.
    Reinhard, C.
    Anchling, L.
    Afonso, J.
    Schuster, T.
    Gerhold, C. B.
    Ricken, B.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : I308 - I309
  • [10] Clinical Use of Infliximab Trough Levels and Antibodies to Infliximab in Pediatric Patients With Inflammatory Bowel Disease
    Merras-Salmio, Laura
    Kolho, Kaija-Leena
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2017, 64 (02): : 272 - 278
12345